[Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies]

Verena Keitel1, Stephan Vom Dahl1, Dieter Häussinger1

  • 1Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf.

Insights

Recognizing secondary causes of fatty liver disease, like viral infections or metabolic disorders, is crucial for targeted treatment and preventing progression. Early diagnosis of these underlying conditions improves patient outcomes in fatty liver disease management.

Area of Science:

  • Hepatology
  • Internal Medicine
  • Genetics

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome.
  • Secondary causes of fatty liver disease require specific therapies and are often linked to infections, endocrine disorders, or genetic factors.
  • Genetic polymorphisms in PNPLA3, TM6SF2, and MBOAT7 influence fatty liver disease development and progression.

Purpose of the Study:

  • To emphasize the importance of identifying secondary causes of fatty liver disease.
  • To outline diagnostic strategies for differentiating NAFLD from secondary etiologies.
  • To highlight the role of genetic factors in fatty liver disease pathogenesis.

Main Methods:

  • Assessment of metabolic syndrome features and alcohol consumption.
  • Screening for hepatitis C virus (HCV) infection, hypothyroidism, and drug-induced steatosis.
  • Evaluation for genetic disorders like Wilson's disease, hemochromatosis, celiac disease, and lipid metabolism disorders.
  • Consideration of extended endocrinological workup and liver biopsy when etiology remains unclear.

Main Results:

  • Secondary causes, including HCV, endocrine diseases, nutritional issues, and genetic factors, contribute significantly to fatty liver disease.
  • Metabolic syndrome is frequently associated with NAFLD.
  • Specific genetic variants can exacerbate steatosis and disease progression.

Conclusions:

  • Diagnosing secondary causes of fatty liver disease enables targeted therapeutic interventions.
  • Comprehensive workup, including genetic screening, is essential for managing fatty liver disease effectively.
  • Early identification and treatment of secondary causes can prevent disease progression to fibrosis and cirrhosis.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
438
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.6K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
246
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
621
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
132